UK
UK
Apr-15
Endocrinology Gastroenterology Oncology Pharmacoepidemiology
Read moreApr-15
Endocrinology Pharmacoepidemiology
Read moreFeb-15
Cardiovascular Endocrinology Ophthalmology
Read moreFeb-15
Endocrinology Pharmacoepidemiology
Read moreFeb-15
Cardiovascular Database Endocrinology
Read moreDec-14
Nov-14
Sep-14
Endocrinology Pharmacoepidemiology
Read moreSep-14
Demographics Endocrinology Oncology
Read moreSep-14
Endocrinology General Analysis
Read moreSep-14
Cardiovascular Endocrinology Nephrology
Read moreSep-14
Endocrinology Healthcare Cost Pharmacoepidemiology
Read more| Date | Title | Categories | Type | |
|---|---|---|---|---|
| Apr-15 | Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk |
Endocrinology Gastroenterology Oncology Pharmacoepidemiology |
Full Article | Read more |
| Apr-15 | Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs | Full Article | Read more | |
| Feb-15 | Diabetes, cardiovascular morbidity, and risk of age-related macular degeneration in a primary care population | Full Article | Read more | |
| Feb-15 | Proton pump inhibitors do not impair the effectiveness of metformin in patients with diabetes | Full Article | Read more | |
| Feb-15 | Refitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK | Full Article | Read more | |
| Dec-14 | Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK | Full Article | Read more | |
| Nov-14 | Comparing the Use of Patient-Level Data to An Average Patient Profile Within a Type 2 Diabetes Simulation Model | Abstract | Read more | |
| Sep-14 | Predictors of glycaemic response to add-on therapy with a DPP-IV inhibitor: a retrospective cohort study using the primary care THIN database | Abstract | Read more | |
| Sep-14 | Sociodemographic trends in the incidence of pancreatic and biliary tract cancer in UK primary care | Full Article | Read more | |
| Sep-14 | A global study of unmet need for glycaemic control and predictor factors among patients with type 2 diabetes mellitus | Abstract | Read more | |
| Sep-14 | Cardiovascular events and all-cause mortality: associations with renal function in patients with type 2 diabetes | Abstract | Read more | |
| Sep-14 | The cost-effectiveness of canagliflozin (CANA) versus sitagliptin (SITA) as third-line therapy in the treatment of type 2 diabetes mellitus (T2DM) in the UK | Abstract | Read more |
